Log in to save to my catalogue

A human bispecific antibody neutralizes botulinum neurotoxin serotype A

A human bispecific antibody neutralizes botulinum neurotoxin serotype A

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_865d5734adf74d28a42392142e6f3a49

A human bispecific antibody neutralizes botulinum neurotoxin serotype A

About this item

Full title

A human bispecific antibody neutralizes botulinum neurotoxin serotype A

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-11, Vol.13 (1), p.20806-20806, Article 20806

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Botulinum neurotoxin (BoNT) shows high lethality and toxicity, marking it as an important biological threat. The only effective post-exposure therapy is botulinum antitoxin; however, such products have great potential for improvement. To prevent or treat BoNT, monoclonal antibodies (mAbs) are promising agents. Herein, we aimed to construct a bispec...

Alternative Titles

Full title

A human bispecific antibody neutralizes botulinum neurotoxin serotype A

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_865d5734adf74d28a42392142e6f3a49

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_865d5734adf74d28a42392142e6f3a49

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-48008-5

How to access this item